Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients — Stella

Recruiting

Back to Congenital Bleeding Disorder trials

Trial locations(7 sites)

Iraq

National centre for Hamophilia, Baghdad

Novo Nordisk Investigational Site, Baghdad

Basrah Haemoplhilia centre, Basra

Hilla Haemophilia centre, Hillah

Karbala Haemophilia centre, Karbala

Kirkuk Centre for Cancer and Blood Disorders, Kirkuk

Najaf Haemophilia Centre, Najaf

Key details

Sponsor

Novo Nordisk A/S

Enrollment target

~900 participants

Started

November 2024

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Sex

Male only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov